文献速递血管炎

年龄相关B细胞通过非抗体依赖机制参与大动脉炎炎症

Age-Associated B Cells Contribute to Inflammation Via Antibody-Independent Mechanisms in Takayasu Arteritis.
PubMed 文献 · Arthritis Rheumatol · 2026-08-04

本研究探讨大动脉炎(TAK)中B细胞激活途径及其致病作用,通过组织学、转录组学、流式细胞术及体外实验发现TAK存在滤泡外反应和年龄相关B细胞(ABC)生成上调,ABC分化与抗体分泌细胞生成解耦,且ABC具有促炎特性并促进Th17分化。体外实验显示托法替尼较阿达木单抗更有效降低ABC比例并减弱其促炎表型。

要点

  • TAK中ABC生成上调且分化与抗体分泌细胞生成解耦。
  • ABC通过促炎细胞因子产生和促进Th17分化发挥促炎作用。
  • 托法替尼体外抑制ABC效果优于阿达木单抗。

核心结论

  • ABCs通过不依赖抗体分泌细胞分化的促炎功能促进TAK炎症。
  • JAK抑制对ABCs的抑制作用与抗TNF治疗不同。

研究设计与样本

  • 组织学分析(n=5)旁血管淋巴结和受累动脉。
  • 流式细胞术(n=125)和bulk RNA-seq(n=12)分析B细胞。
  • 单细胞RNA-seq和体外实验(n=5)分析ABC分化。
  • 体外实验(n=6)分析CD11c+ B细胞促Th17分化。
  • 体外实验(n=15)比较托法替尼与阿达木单抗对ABC的影响,并探索性临床随访(n=4)。

主要发现

  • 组织学、流式细胞术和bulk RNA-seq分析提示TAK存在滤泡外反应和ABC生成上调。
  • TAK与SLE的B细胞转录组存在跨数据集差异。
  • 跨数据集scRNA-seq和体外实验(n=5)表明TAK中ABC分化 largely uncoupled from 抗体分泌细胞生成,与SLE不同。
  • ABCs产生促炎细胞因子,CD11c+ B细胞(含ABC区室)促进Th17细胞分化(n=6)。
  • 体外托法替尼较阿达木单抗更有效降低ABC比例并减弱其促炎表型(n=15),与探索性临床随访(n=4)趋势一致。

临床怎么用

  • JAK抑制可能通过抑制ABCs对TAK发挥治疗作用,需进一步临床验证。
  • ABCs及其促炎功能可作为TAK潜在治疗靶点。

局限性

  • 探索性临床随访样本量小(n=4),需更大规模研究验证。
  • 机制发现主要基于体外实验和观察性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although Takayasu arteritis (TAK) is not a prototypical autoantibody-mediated disease, accumulating evidence suggests that B cells are involved. This study aimed to investigate the pathway of B cell activation and its contributions to TAK pathogenesis. METHODS: Histologic analysis of paravascular lymph nodes and affected arteries was conducted to investigate B cell activation pathways in TAK. Bulk RNA-seq, single-cell RNA-seq (scRNA-seq), flow cytometry, and in vitro experiments were performed to characterize the composition, transcriptomic features, and functional profiles of B cells. The numeric and phenotypic alterations induced by tumor necrosis factor (TNF) and JAK inhibition were assessed both in vitro and in four patients with TAK. RESULTS: Histologic (n = 5), flow cytometric (n = 125), and bulk RNA-seq (n = 12) analyses indicated the presence of extrafollicular response and up-regulated age-associated B cell (ABC) production in TAK, along with cross-data set transcriptomic differences between B cells from patients with TAK and systemic lupus erythematosus (SLE). Cross-data set scRNA-seq analysis and in vitro experiments (n = 5) demonstrated that ABC differentiation in TAK was largely uncoupled from antibody-secreting cell (ASC) generation, unlike that in SLE. Functional experiments showed that ABCs exhibited proinflammatory properties, including proinflammatory cytokine production, and that CD11c+ B cells, which contain the ABC compartment, promoted Th17 cell differentiation (n = 6). In vitro, tofacitinib was more effective than adalimumab at reducing ABC proportions and attenuating their proinflammatory phenotype (n = 15), consistent with trends in the exploratory clinical follow-up (n = 4). CONCLUSION: ABCs promote inflammation through proinflammatory functions independent of ASC differentiation in TAK. JAK inhibition exerts distinct suppressive effects on ABCs compared with anti-TNF therapy.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Fang C, Yang X, Sun X, et al. Age-Associated B Cells Contribute to Inflammation Via Antibody-Independent Mechanisms in Takayasu Arteritis. Arthritis Rheumatol. 2026. PMID: 42549483. doi:10.1002/art.70284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。